Clinical Trial
doi: 10.1016/s0140-6736(70)91365-6.
Combined treatment of parkinsonism with L-dopa and amantadine
- PMID: 4195220
- DOI: 10.1016/s0140-6736(70)91365-6
Item in Clipboard
Clinical Trial
Combined treatment of parkinsonism with L-dopa and amantadine
Lancet.
.
No abstract available
Similar articles
-
Combined treatment of parkinsonism with L-dopa and amantadine.Lancet. 1970 Aug 22;2(7669):383-5. doi: 10.1016/s0140-6736(70)90002-4. Lancet. 1970. PMID: 4194690 Clinical Trial. No abstract available.
-
L-dopa and amantadine in the therapy of parkinsonism.Wis Med J. 1969 Nov;68(11):325-8. Wis Med J. 1969. PMID: 4901055 Clinical Trial. No abstract available.
-
Combined L-dopa and amantadine in Parkinsonism.Aust N Z J Med. 1972 Aug;2(3):252-5. doi: 10.1111/j.1445-5994.1972.tb03070.x. Aust N Z J Med. 1972. PMID: 4564049 Clinical Trial. No abstract available.
-
[Advances in the treatment of parkinsonism].Neurol Neurochir Pol. 1972 Mar-Apr;6(2):275-80. Neurol Neurochir Pol. 1972. PMID: 4555308 Review. Polish. No abstract available.
-
Pyridoxine, DOPA, and Parkinsonism.Adv Biochem Psychopharmacol. 1972;4:185-94. Adv Biochem Psychopharmacol. 1972. PMID: 4555927 Review. No abstract available.
Cited by
-
Amantadine in Parkinson's disease.Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468. Cochrane Database Syst Rev. 2003. PMID: 12535476 Free PMC article.
-
Levodopa and orphenadrine hydrochloride in Parkinsonism.Eur J Clin Pharmacol. 1971 Dec;4(1):18-21. doi: 10.1007/BF00568893. Eur J Clin Pharmacol. 1971. PMID: 4948768 Clinical Trial. No abstract available.
-
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002. Drugs. 1971. PMID: 4340597 Review. No abstract available.
-
Treatment for Parkinsonism, other than levodopa.Br Med J. 1972 Mar 18;1(5802):741-2. doi: 10.1136/bmj.1.5802.741. Br Med J. 1972. PMID: 5015332 Free PMC article. No abstract available.
-
Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.Can Med Assoc J. 1971 Jul 10;105(1):42-6 passim. Can Med Assoc J. 1971. PMID: 4932544 Free PMC article. Clinical Trial.